Analytical Data
-
Gene name
DNHD1
- Application
-
Alternative Names
CCDC35; DHCD1; DNHD1L; C11orf47; Dynein heavy chain domain 1-like protein
-
Species
Human
-
Source
E. coli
-
Tag
N- His & GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96M86
-
Expression Region
Met1~Pro302
-
Molecular Weight
64kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DNHD1 (DYNASPINE) is a member of the Dynein Heavy Chain Family, and emerging research highlights its crucial role in cellular processes including mitosis and intracellular transport. The protein is known to interact with various cellular components, influencing key aspects of cell signaling and organelle dynamics. Mutations or dysregulation of DNHD1 have been implicated in several neurodegenerative diseases and developmental disorders, prompting interest in understanding its functional mechanisms. Recent studies focus on the recombinant expression of DNHD1 to explore its structural and biophysical properties. This research aims to elucidate the protein's interactions and functional dynamics, which may pave the way for therapeutic interventions targeting DNHD1-related pathways. By utilizing modern techniques in protein engineering and characterization, researchers are working towards establishing a comprehensive understanding of DNHD1's role in cellular physiology, which may contribute to novel strategies in the treatment of diseases linked to its dysfunction.
